Posted by Michael Wonder on 30 May 2022
Takeda says drug makers could cut prices in face of global crises
30 May 2021 - The head of Asia’s largest pharmaceutical company said the risk of a global recession, along with the impact of COVID-19 and the war in Ukraine, could force the industry to cut drug prices.
Christophe Weber, chief executive of Takeda, which is headquartered in Tokyo, said pressure on government health care budgets had increased this year due to the costs of combating multiple crises, such as the pandemic, the Russia-Ukraine war and investments related to climate change.
